Related Experiment Video
Updated: May 4, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple local relapses: case presentation and brief
A Patsatsi1, A Kyriakou1, V Karavasilis2
12 Dermatology Department.
Insights
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBL-LT) is an intermediate-behaving B-cell lymphoma primarily affecting elderly individuals. This case highlights PCDLBL-LT
Area of Science:
- Dermatology
- Oncology
- Hematology
Background:
- Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBL-LT) is a distinct subtype of non-Hodgkin lymphoma.
- This lymphoma typically exhibits intermediate behavior and predominantly affects elderly patients.
Observation:
- A 76-year-old male presented with characteristic red to violaceous nodules on the anterior aspects of both tibias.
- Histopathological examination confirmed PCDLBL-LT. Systemic involvement was ruled out, but thoracic CT revealed mediastinal lymphadenopathy.
Findings:
- The patient initially responded well to R-CHOP chemotherapy, achieving complete lesion clearance.
- However, the patient experienced a relapse five months later, necessitating palliative radiotherapy, which was also used for a subsequent recurrence.
Implications:
- PCDLBL-LT predominantly affects the elderly, often presenting with age-related comorbidities.
- The tendency for frequent relapses in PCDLBL-LT underscores the critical need for stringent patient follow-up and tailored management strategies.
Abstract:
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBL-LT) is a primary cutaneous B-cell lymphoma of intermediate behavior. The disease predominantly affects elderly patients. A 76-year old man presented with red to violaceous nodules in the anterior aspect of both tibias. Histology confirmed the diagnosis of PCDLBL-LT. A thorough clinical and laboratory investigation was negative for any systemic involvement. However, computed tomography of the thorax showed mediastinal lymphadenopathy. Both bone marrow aspiration and trephine did not show any evidence of bone marrow infiltration. Initially R-CHOP regimen (rituximab-cyclophosphamide, doxorubicin, vincristine, prednisone) achieved a total clearance of the lesions. Nevertheless, five months later patient presented with a relapse and was managed with palliative radiotherapy. The same treatment modality was applied for the second recurrence, as well. PCDLBL-LT affects mostly elderly patients. The consequent age related comorbidities and the frequent relapses require a strict follow up of the patients.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Multiple Sclerosis l: Introduction

